Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Patent

Windtree Therapeutics
Regional

Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment

July 4, 2025July 3, 2025 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous treatment …

Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment Read More

Palvella Therapeutics
Business

Palvella Therapeutics Secures New Patent for QTORIN™ Rapamycin

June 18, 2025June 18, 2025 - by Timothy Alexander

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the issuance of U.S. patent No. 12,329,748 by the United States Patent and Trademark Office (USPTO), providing increased protection for its …

Palvella Therapeutics Secures New Patent for QTORIN™ Rapamycin Read More
Orchestra BioMed Holdings
Regional

Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation

May 11, 2025May 10, 2025 - by Timothy Alexander

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced significant advancements in the intellectual property backing its AVIM (Atrioventricular Interval Modulation) therapy pipeline. Over the past year, …

Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation Read More

Rajant Health
Business

Rajant Health Secures Patent for Cutting-Edge Wearable Monitoring Technology

May 9, 2025May 8, 2025 - by Timothy Alexander

MALVERN, PA — Rajant Health Incorporated (RHI) has been granted a new patent for its innovative Parallel Adaptive Motion Artifact Removal technology, marking a major advancement in wearable health monitoring …

Rajant Health Secures Patent for Cutting-Edge Wearable Monitoring Technology Read More
Palvella Therapeutics
Business

Palvella Therapeutics Secures New U.S. Patent for QTORIN Rapamycin

April 23, 2025April 22, 2025 - by Timothy Alexander

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has secured its fifth U.S. patent for QTORIN™ 3.9% rapamycin anhydrous gel, reinforcing its position in the development of treatments for rare …

Palvella Therapeutics Secures New U.S. Patent for QTORIN Rapamycin Read More

PleoPharma
Business

PleoPharma Secures Patent for Treating Sleep Disturbances in Cannabis Withdrawal

April 21, 2025April 20, 2025 - by Timothy Alexander

PHOENIXVILLE, PA — PleoPharma, Inc. has announced a significant intellectual property milestone with the issuance of its third U.S. patent, aimed at addressing sleep disturbances linked to cannabis withdrawal syndrome …

PleoPharma Secures Patent for Treating Sleep Disturbances in Cannabis Withdrawal Read More
Windtree Therapeutics
Regional

Windtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failure

March 5, 2025March 4, 2025 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application number …

Windtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failure Read More

Annovis Bio
Business

Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap

January 17, 2025January 15, 2025 - by Timothy Alexander

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has been granted a U.S. patent for the use of its leading compound, buntanetap, in the treatment and prevention of acute brain and …

Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap Read More
Sojo Industries
Regional

Sojo Industries Secures U.S. Patent for Revolutionary Sojo Flight System

November 19, 2024November 18, 2024 - by Timothy Alexander

BRISTOL, PA — Sojo Industries has been awarded a U.S. patent for its groundbreaking Mobile Automated Modular Variety and Multi-pack Production Line and System Solution, known as Sojo Flight™. This …

Sojo Industries Secures U.S. Patent for Revolutionary Sojo Flight System Read More
Windtree Therapeutics
Regional

Windtree Therapeutics Secures Hong Kong Patent for Istaroxime in Heart Failure Treatment

November 6, 2024November 6, 2024 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the issuance of a new patent for istaroxime in Hong Kong, titled “Istaroxime-containing intravenous formulation for the treatment of heart …

Windtree Therapeutics Secures Hong Kong Patent for Istaroxime in Heart Failure Treatment Read More

Posts pagination

1 2 3 Next

Trending News

  • Off-Duty Officer Gets Probation After Guilty Plea in Fatal Walmart Confrontation

  • Seven Arrested in Philadelphia Gun and Drug Raids: AG Calls Suspects “Dangerous Offenders” Threatening Neighborhoods

  • Wilmington Man Nabbed in Claymont Bank Heist After Nearly a Year on the Run

  • Manhunt Underway for 19-Year-Old Wanted in Violent Horsham Armed Robbery and Assault

  • Hatboro Man Arrested for Allegedly Posing as Police Officer During Traffic Stop

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Court News

Off-Duty Officer Gets Probation After Guilty Plea in Fatal Walmart Confrontation

July 16, 2025July 16, 2025

Evidence

Seven Arrested in Philadelphia Gun and Drug Raids: AG Calls Suspects “Dangerous Offenders” Threatening Neighborhoods

July 16, 2025July 16, 2025

Gregory Davis

Wilmington Man Nabbed in Claymont Bank Heist After Nearly a Year on the Run

July 16, 2025July 16, 2025

Copyright © 2025 MyChesCo.